Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
about
Personalized medicine for lung cancer: new challenges for pathology.Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma.[Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
P2860
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@en
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@nl
type
label
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@en
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@nl
prefLabel
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@en
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@nl
P2093
P2860
P356
P1476
Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
@en
P2093
Dennis A Wigle
Marianne Huebner
Sandra C Tomaszek
P2860
P304
P356
10.1586/ERS.10.40
P577
2010-08-01T00:00:00Z